A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis

Injectable regenerative therapies such as bone marrow concentrate (BMC) and platelet-rich plasma (PRP) may represent a safe alternative in the treatment of rotator cuff tears. This is a midterm review of a randomized, crossover trial comparing autologous BMC and platelet product injections versus ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher Centeno, Zachary Fausel, Ian Stemper, Ugochi Azuike, Ehren Dodson
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2020/5962354
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567954433114112
author Christopher Centeno
Zachary Fausel
Ian Stemper
Ugochi Azuike
Ehren Dodson
author_facet Christopher Centeno
Zachary Fausel
Ian Stemper
Ugochi Azuike
Ehren Dodson
author_sort Christopher Centeno
collection DOAJ
description Injectable regenerative therapies such as bone marrow concentrate (BMC) and platelet-rich plasma (PRP) may represent a safe alternative in the treatment of rotator cuff tears. This is a midterm review of a randomized, crossover trial comparing autologous BMC and platelet product injections versus exercise therapy in the treatment of partial and full-thickness supraspinatus tears. Patients enrolled into the study were between 18 and 65 years of age presenting to an outpatient orthopedic clinic with partial to full thickness, nonretracted supraspinatus tendon tears. Enrolled patients were randomized to either ultrasound-guided autologous BMC with PRP and platelet lysate (PL) percutaneous injection treatment or exercise therapy. Patients could cross over to BMC treatment after at least 3 months of exercise therapy. Patients completed the Disability of the Arm, Shoulder and Hand (DASH) scores as the primary outcome measure. Secondary outcomes included the numeric pain scale (NPS), a modified Single Assessment Numeric Evaluation (SANE), and a blinded MRI review. At this midterm review, results from 25 enrolled patients who have reached at least 12-month follow-up are presented. No serious adverse events were reported. Significant differences were seen in patient reported outcomes for the BMC treatment compared to exercise therapy at 3 and 6 months for pain, and for function and reported improvement (SANE) at 3 months (p<.05). Patients reported a mean 89% improvement at 24 months, with sustained functional gains and pain reduction. MRI review showed a size decrease of most tears post-BMC treatment. These findings suggest that ultrasound-guided BMC and platelet product injections are a safe and useful alternative to conservative exercise therapy of torn, nonretracted supraspinatus tendons. This trial is registered with NCT01788683.
format Article
id doaj-art-a575fa99d3a14af19aa87b6e979cf94a
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-a575fa99d3a14af19aa87b6e979cf94a2025-02-03T01:00:06ZengWileyStem Cells International1687-966X1687-96782020-01-01202010.1155/2020/59623545962354A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm AnalysisChristopher Centeno0Zachary Fausel1Ian Stemper2Ugochi Azuike3Ehren Dodson4Centeno-Schultz Clinic, 403 Summit Blvd 201, Broomfield, Colorado 80021, USACenteno-Schultz Clinic, 403 Summit Blvd 201, Broomfield, Colorado 80021, USARegenexx, LLC, 6151 Thornton Ave #200, Des Moines, Iowa 50321, USACenteno-Schultz Clinic, 403 Summit Blvd 201, Broomfield, Colorado 80021, USARegenexx, LLC, 6151 Thornton Ave #200, Des Moines, Iowa 50321, USAInjectable regenerative therapies such as bone marrow concentrate (BMC) and platelet-rich plasma (PRP) may represent a safe alternative in the treatment of rotator cuff tears. This is a midterm review of a randomized, crossover trial comparing autologous BMC and platelet product injections versus exercise therapy in the treatment of partial and full-thickness supraspinatus tears. Patients enrolled into the study were between 18 and 65 years of age presenting to an outpatient orthopedic clinic with partial to full thickness, nonretracted supraspinatus tendon tears. Enrolled patients were randomized to either ultrasound-guided autologous BMC with PRP and platelet lysate (PL) percutaneous injection treatment or exercise therapy. Patients could cross over to BMC treatment after at least 3 months of exercise therapy. Patients completed the Disability of the Arm, Shoulder and Hand (DASH) scores as the primary outcome measure. Secondary outcomes included the numeric pain scale (NPS), a modified Single Assessment Numeric Evaluation (SANE), and a blinded MRI review. At this midterm review, results from 25 enrolled patients who have reached at least 12-month follow-up are presented. No serious adverse events were reported. Significant differences were seen in patient reported outcomes for the BMC treatment compared to exercise therapy at 3 and 6 months for pain, and for function and reported improvement (SANE) at 3 months (p<.05). Patients reported a mean 89% improvement at 24 months, with sustained functional gains and pain reduction. MRI review showed a size decrease of most tears post-BMC treatment. These findings suggest that ultrasound-guided BMC and platelet product injections are a safe and useful alternative to conservative exercise therapy of torn, nonretracted supraspinatus tendons. This trial is registered with NCT01788683.http://dx.doi.org/10.1155/2020/5962354
spellingShingle Christopher Centeno
Zachary Fausel
Ian Stemper
Ugochi Azuike
Ehren Dodson
A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
Stem Cells International
title A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
title_full A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
title_fullStr A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
title_full_unstemmed A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
title_short A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis
title_sort randomized controlled trial of the treatment of rotator cuff tears with bone marrow concentrate and platelet products compared to exercise therapy a midterm analysis
url http://dx.doi.org/10.1155/2020/5962354
work_keys_str_mv AT christophercenteno arandomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT zacharyfausel arandomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ianstemper arandomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ugochiazuike arandomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ehrendodson arandomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT christophercenteno randomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT zacharyfausel randomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ianstemper randomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ugochiazuike randomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis
AT ehrendodson randomizedcontrolledtrialofthetreatmentofrotatorcufftearswithbonemarrowconcentrateandplateletproductscomparedtoexercisetherapyamidtermanalysis